YAG Laser Vitreolysis for Vitreous Floaters

Part of paid clinical trials in Huntington Beach, California.

Sponsor
VMR Consulting, Inc.
Study ID
NCT06915922
Status
Recruiting
Apply to this trial

Conditions

  • Myopic Vitreopathy
  • Posterior Vitreous Detachment
  • VISION DEGRADING MYODESOPSIA

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Neodymium-doped yttrium-aluminum-garnet (Nd:YAG) laser therapy — DEVICE
    Nd:YAG laser treatment(s) for Vision Degrading Myodesopsia (clinically significant vitreous floaters) in eyes with vitreous opacities due to myopic vitreopathy and posterior vitreous detachment (PVD).

Study Details

The purpose of this study is to measure how the quality of life, the structure of eye, and vision change after treatment for the opacities in the gel (vitreous) that fills the center of eye which cause vision disturbances commonly called "floaters". In this study the vitreous floaters are treated using a Neodymium-doped yttrium-aluminum-garnet (Nd:YAG) laser. The FDA has approved the use of this laser to treat membranes in the eye.

Key Dates

Start date
Oct 17, 2023
Status verified
Feb 2026
Primary completion
May 31, 2026
Completion
May 31, 2026

Study Design

Enrollment
50 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Other: Neodymium-doped Yttrium-Aluminum-Garnet (Nd:YAG) Laser Vitreolysis

Primary Outcome Measure

Measures of vitreous structure by quantitative ultrasonography [ Time Frame: baseline, 3 months, 6 months, 12 months ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
VMR Institute for Vitreous Macula RetinaHuntington BeachCalifornia92647
Dr. Jerry Sebag, MD, FACS, FRCOphth, FARVO
[email protected]
714-901-7777

Find similar trials in Huntington Beach, CA

By research site
VMR Institute for Vitreous Macula Retina· Huntington Beach, CA

Related Studies